三鑫医疗
(300453)
| 流通市值：26.58亿 | | | 总市值：38.03亿 |
| 流通股本：3.63亿 | | | 总股本：5.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 331,158,893.25 | 1,300,060,980.74 | 929,961,012.41 | 581,745,548.36 |
| 营业收入 | 331,158,893.25 | 1,300,060,980.74 | 929,961,012.41 | 581,745,548.36 |
| 二、营业总成本 | 272,638,774.3 | 1,075,802,050.82 | 771,379,171.83 | 482,735,379.56 |
| 营业成本 | 215,915,661.02 | 846,499,413.35 | 610,055,871.88 | 386,274,648.27 |
| 税金及附加 | 2,525,757.64 | 10,279,830.04 | 7,694,731.81 | 4,545,601.67 |
| 销售费用 | 19,916,743.77 | 78,307,179.1 | 54,462,350.94 | 32,712,377.25 |
| 管理费用 | 23,136,854.03 | 91,406,915.61 | 66,891,055.41 | 43,106,982.48 |
| 研发费用 | 12,130,470.58 | 51,065,299.57 | 34,200,080.78 | 18,633,542 |
| 财务费用 | -986,712.74 | -1,756,586.85 | -1,924,918.99 | -2,537,772.11 |
| 其中:利息费用 | 840,252.9 | 4,519,376.41 | 3,786,293.23 | 2,395,804.47 |
| 其中:利息收入 | 1,110,921.16 | 6,320,687.89 | 5,776,935.61 | 5,173,989.6 |
| 加:公允价值变动收益 | 2,160,753.88 | 1,297,864.37 | - | - |
| 加:投资收益 | -109,476.86 | 9,689,333.52 | 750,267.43 | 447,368.14 |
| 资产处置收益 | 192,035.52 | 161,139.26 | 137,427.55 | 137,427.55 |
| 资产减值损失(新) | 406,568.86 | -792,712.81 | -1,258,534.63 | -605,446.88 |
| 信用减值损失(新) | -1,823,356.91 | -1,171,170.89 | -1,787,273.06 | -1,196,104.91 |
| 其他收益 | 5,986,622.71 | 24,197,230.62 | 14,892,737.08 | 11,084,428.05 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 65,333,266.15 | 257,640,613.99 | 171,316,464.95 | 108,877,840.75 |
| 加:营业外收入 | 363,364 | 1,847,694.05 | 2,539,035.45 | 1,864,208.76 |
| 减:营业外支出 | 558,238.71 | 6,717,575.49 | 1,995,232.42 | 519,069.89 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 65,138,391.44 | 252,770,732.55 | 171,860,267.98 | 110,222,979.62 |
| 减:所得税费用 | 7,468,012.47 | 29,536,336.85 | 19,853,134.26 | 13,665,953.15 |
| 六、净利润 | 57,670,378.97 | 223,234,395.7 | 152,007,133.72 | 96,557,026.47 |
| 持续经营净利润 | 57,670,378.97 | 223,234,395.7 | 152,007,133.72 | 96,557,026.47 |
| 归属于母公司股东的净利润 | 53,618,659.09 | 206,633,857.16 | 141,410,327.37 | 89,479,881.4 |
| 少数股东损益 | 4,051,719.88 | 16,600,538.54 | 10,596,806.35 | 7,077,145.07 |
| (一)基本每股收益 | 0.1 | 0.4 | 0.27 | 0.17 |
| (二)稀释每股收益 | 0.1 | 0.4 | 0.27 | 0.17 |
| 九、综合收益总额 | 57,670,378.97 | 223,234,395.7 | 152,007,133.72 | 96,557,026.47 |
| 归属于母公司股东的综合收益总额 | 53,618,659.09 | 206,633,857.16 | 141,410,327.37 | 89,479,881.4 |
| 归属于少数股东的综合收益总额 | 4,051,719.88 | 16,600,538.54 | 10,596,806.35 | 7,077,145.07 |
| 公告日期 | 2024-04-17 | 2024-03-23 | 2023-10-21 | 2023-08-05 |
| 审计意见(境内) | | 标准无保留意见 | | |